Document Detail

Adverse pregnancy outcomes after abnormal first-trimester screening for aneuploidy.
MedLine Citation:
PMID:  20638576     Owner:  NLM     Status:  MEDLINE    
Women with abnormal results of first trimester screening but with a normal karyotype are at risk for adverse pregnancy outcomes. A nuchal translucency of greater than 3.5 mm is associated with an increased risk of subsequent pregnancy loss, fetal infection, fetal heart abnormalities, and other structural abnormalities. Abnormal levels of first trimester analytes are also associated with adverse pregnancy outcomes, but the predictive value is less impressive. As a single marker, pregnancy-associated plasma protein (PAPP)-A level less than 1st percentile has a good predictive value for subsequent fetal growth restriction. Women with PAPP-A level less than 5th percentile should undergo subsequent risk assessment with routine maternal serum afetoprotein screening with the possible addition of uterine artery pulsatility index assessment in the midtrimester.
Laura Goetzl
Related Documents :
23825686 - Transgenic increase in n-3/n-6 fatty acid ratio reduces maternal obesity-associated inf...
12441696 - The role of fetal nuchal translucency in prenatal screening.
21098846 - Model-predicted performance of second-trimester down syndrome screening with sonographi...
14709646 - Invasive trophoblast antigen (hyperglycosylated human chorionic gonadotropin) in second...
19079956 - Randomized controlled pilot trial of luteal phase recombinant fsh stimulation in poor r...
12364476 - Oxygen regulation of placental 11 beta-hydroxysteroid dehydrogenase 2: physiological an...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Clinics in laboratory medicine     Volume:  30     ISSN:  1557-9832     ISO Abbreviation:  Clin. Lab. Med.     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-07-19     Completed Date:  2010-11-08     Revised Date:  2013-05-29    
Medline Journal Info:
Nlm Unique ID:  8100174     Medline TA:  Clin Lab Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  613-28     Citation Subset:  IM    
Copyright Information:
Copyright 2010 Elsevier Inc. All rights reserved.
Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Medical University of South Carolina, 96 Jonathan Lucas Street, Charleston, SC 29425, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Congenital Abnormalities / blood,  diagnosis,  genetics*
Mass Screening
Nuchal Translucency Measurement
Predictive Value of Tests
Pregnancy Outcome
Pregnancy Trimester, First*
Grant Support
R01 HD031991-03/HD/NICHD NIH HHS; R01 HD032109-04/HD/NICHD NIH HHS

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Clinical Implications of First-Trimester Screening.
Next Document:  Cost-Effectiveness of Down Syndrome Screening Paradigms.